Gelteq Limited (GELS)
NASDAQ: GELS · Real-Time Price · USD
1.080
+0.020 (1.89%)
At close: Nov 28, 2025, 1:00 PM EST
1.100
+0.020 (1.85%)
After-hours: Nov 28, 2025, 4:39 PM EST
Gelteq Revenue
In the fiscal year ending June 30, 2025, Gelteq had annual revenue of 413.13K AUD with 188.27% growth. Gelteq had revenue of 101.72K in the half year ending June 30, 2025.
Revenue (ttm)
413.13K AUD
Revenue Growth
+188.27%
P/S Ratio
36.97
Revenue / Employee
51,642 AUD
Employees
8
Market Cap
11.57M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 413.13K | 269.82K | 188.27% |
| Jun 30, 2024 | 143.31K | -199.59K | -58.21% |
| Jun 30, 2023 | 342.90K | -29.17K | -7.84% |
| Jun 30, 2022 | 372.07K | 212.20K | 132.73% |
| Jun 30, 2021 | 159.87K | - | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
GELS News
- 5 days ago - Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform - GlobeNewsWire
- 14 days ago - Healthy Extracts Reports Record Q3 2025, with Revenue up 23% - Accesswire
- 18 days ago - Nutraceutical Technology Leader, Healthy Extracts, Invited to Present at the Trickle Research Microcap Conference on November 13, 2025 - Accesswire
- 2 months ago - Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner - GlobeNewsWire
- 3 months ago - Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market - GlobeNewsWire
- 3 months ago - Healthy Extracts Builds Upon Record Q2 Results and Transformative Merger with Launch of New Revolutionary Hydration and Sugar Metabolism Gel-Packs - Accesswire
- 3 months ago - Healthy Extracts Reports Record Q2 2025 Net Revenue, Driving Positive EPS and EBITDA; Increases 2025 Net Revenue Guidance by 50% - Accesswire
- 4 months ago - Healthy Extracts Expects Record Sales for Q2 2025, Driving Strong Positive Adj. EBITDA - Accesswire